Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Casey

Showing results (371-380 of 429) with videos related to

Pageof 43
Sort By:
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Annals of Emergency Medicine|October 10, 2024
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized TrialsStephanie C DeMasi, Wesley H Self, Neil R Aggarawal, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
Pageof 43

Showing results (371-380 of 429) with videos related to

Sort By:
Pageof 43
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Annals of Emergency Medicine|October 10, 2024
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized TrialsStephanie C DeMasi, Wesley H Self, Neil R Aggarawal, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
Pageof 43